Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
About
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship. Applications should include hypothesis-based research, support for cohort infrastructure and/or maintenance, continued follow-up, and sharing of data and biospecimen resources as appropriate.
The Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) grant, administered by the National Cancer Institute (NCI), supports researchers and institutions conducting hypothesis-based cancer epidemiology research through established cohort studies. This funding opportunity is designed for organizations that investigate cancer etiology and survivorship while addressing critical knowledge gaps in these areas. The grant supports multiple research activities including cohort infrastructure development and maintenance, continued follow-up of study participants, and the sharing of data and biospecimen resources. Researchers and institutions with existing or planned cohort studies focused on understanding cancer causes, risk factors, and survivor outcomes should consider applying. This grant is particularly valuable for teams seeking to leverage longitudinal data collection and biospecimen repositories to advance cancer prevention and survivorship science. Both domestic U.S. organizations and eligible foreign organizations may apply, making this a broadly accessible opportunity for the international cancer research community. The program emphasizes rigorous epidemiological methodology and the potential for research findings to impact cancer prevention and clinical practice.
Funding Facts
● Applications openDeadline
July 5, 2029
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Funding Range
Varies by cycle
Deadline
2029-07-05
Grant Type
federal
Application Cycle
Annual
Best For
Research institutions, universities, cancer centers, and epidemiology research teams with established or planned cohort studies focused on cancer etiology and survivorship
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Frequently Asked Questions
Who is eligible for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)?
Eligibility includes domestic U.S. organizations and foreign organizations that meet NCI criteria. Non-domestic components of U.S. organizations are eligible to apply. However, foreign components as defined in the NIH Grants Policy Statement are not allowed. For detailed eligibility requirements including institutional qualifications and researcher credentials, refer to Section III of the official Notice of Funding Opportunity (NOFO) or visit the NCI website.
How much funding does Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) provide?
Funding amounts vary by cycle and specific project requirements. The grant program does not specify a fixed award amount in this listing. Applicants should consult the official NOFO and NCI website for current funding levels, budget guidelines, and project period information for the specific funding cycle they plan to apply to.
How do I apply for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)?
Applications are submitted through the standard NIH grant application process. Applicants must prepare a competitive grant proposal that includes hypothesis-based research aims, detailed plans for cohort infrastructure and maintenance, follow-up strategies, and data/biospecimen sharing protocols. The next application deadline is July 5, 2029. For complete submission instructions, required forms, and detailed application guidelines, visit the official NCI NOFO page or the NIH grants website (grants.nih.gov).
What can Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) funding be used for?
Funding supports hypothesis-based cancer epidemiology research including: cohort infrastructure development and maintenance, participant follow-up activities, data collection and management, biospecimen banking and analysis, and resources for data and biospecimen sharing with the research community. Funding is not available for clinical trials. Projects must address specific knowledge gaps in cancer etiology (causes and risk factors) or survivorship outcomes. Consult the official NOFO for detailed allowable costs and budget categories.
Last updated: July 5, 2026